Dataset Information

Re-Evaluation of Chemotherapeutic Potential of Pyoktanin Blue.

ABSTRACT: Background: Pyoktanin blue (PB) is used for staining tissues and cells, and it is applied in photodynamic therapy due to its potent bactericidal activity. However, clinical application of PB as an antiviral and antitumor agent has been limited due to its potent toxicity. For clinical application, the antitumor and antiviral activity as well as the neurotoxicity of PB were re-evaluated with a chemotherapeutic index. Methods: Tumor-specificity (TS) was determined by the ratio of CC50 against normal oral cells/oral squamous cell carcinoma (OSCC); neurotoxicity by that of normal oral/neuronal cells; antiviral activity by that of mock-infected/virus-infected cells; and potency-selectivity expression (PSE) by dividing TS by CC50 (OSCC). Results: Antitumor activity of PB (assessed by TS and PSE) was comparable with that of DXR and much higher than that of 5-FU and melphalan. PB induced caspase-3 activation and subG1 cell accumulation in an OSCC cell line (Ca9-22). PB and anticancer drugs showed comparable cytotoxicity against both neuronal cells and OSCC cell lines. PB showed no detectable anti-HIV/HSV activity, in contrast to reverse transferase inhibitors, sulfated glucans, and alkaline extract of leaves of S.P. Conclusions: PB showed first-class anticancer activity and neurotoxicity, suggesting the importance of establishing the safe treatment schedule.

SUBMITTER: Sakagami H

PROVIDER: S-EPMC8305689 | biostudies-literature | 2021 Jun

REPOSITORIES: biostudies-literature

ACCESS DATA

Publications

Re-Evaluation of Chemotherapeutic Potential of Pyoktanin Blue.

Sakagami Hiroshi H Furukawa Toshiko T Satoh Keitaro K Amano Shigeru S Iijima Yosuke Y Koshikawa Takuro T Asai Daisuke D Fukuchi Kunihiko K Takemura Hiromu H Kanamoto Taisei T Yokose Satoshi S

Medicines (Basel, Switzerland) 20210622 7

<b>Background:</b> Pyoktanin blue (PB) is used for staining tissues and cells, and it is applied in photodynamic therapy due to its potent bactericidal activity. However, clinical application of PB as an antiviral and antitumor agent has been limited due to its potent toxicity. For clinical application, the antitumor and antiviral activity as well as the neurotoxicity of PB were re-evaluated with a chemotherapeutic index. <b>Methods:</b> Tumor-specificity (TS) was determined by the ratio of CC<s ...[more]

PMID: 34206186

Similar Datasets

Project description:BackgroundThe chemotherapy of schistosomiasis currently depends on the use of a single drug, praziquantel. In order to develop novel chemotherapeutic agents we are investigating enzymes involved in the epigenetic modification of chromatin. Sirtuins are NAD+ dependent lysine deacetylases that are involved in a wide variety of cellular processes including histone deacetylation, and have been demonstrated to be therapeutic targets in various pathologies, including cancer.Methodology principal findingsIn order to determine whether Schistosoma mansoni sirtuins are potential therapeutic targets we first identified and characterized their protein sequences. Five sirtuins (SmSirt) are encoded in the S. mansoni genome and phylogenetic analysis showed that they are orthologues of mammalian Sirt1, Sirt2, Sirt5, Sirt6 and Sirt7. Both SmSirt1 and SmSirt7 have large insertion in the catalytic domain compared to their mammalian orthologues. SmSirt5 is the only mitochondrial sirtuin encoded in the parasite genome (orthologues of Sirt3 and Sirt4 are absent) and transcripts corresponding to at least five splicing isoforms were identified. All five sirtuins are expressed throughout the parasite life-cycle, but with distinct patterns of expression. Sirtuin inhibitors were used to treat both schistosomula and adult worms maintained in culture. Three inhibitors in particular, Sirtinol, Salermide and MS3 induced apoptosis and death of schistosomula, the separation of adult worm pairs, and a reduction in egg laying. Moreover, Salermide treatment led to a marked disruption of the morphology of ovaries and testes. Transcriptional knockdown of SmSirt1 by RNA interference in adult worms led to morphological changes in the ovaries characterized by a marked increase in mature oocytes, reiterating the effects of sirtuin inhibitors and suggesting that SmSirt1 is their principal target.Conclusion significanceOur data demonstrate the potential of schistosome sirtuins as therapeutic targets and validate screening for selective sirtuin inhibitors as a strategy for developing new drugs against schistosomiasis.

Project description:Through this study, the synergistic behavior of small-molecular-weight, amphiphilic surfactant molecules and the triblock copolymer Pluronic 188 was extensively evaluated based on their ability to formulate nanocarriers with novel properties for the delivery of class II and IV (biopharmaceutical classification system) chemotherapeutic compounds. The combination of four different surfactants at multiple weight ratios and twelve initially formulated nanosystems resulted in four hybrid delivery platforms, which were further studied in terms of multiple physicochemical characteristics, as well as their stability in protein-rich media (fetal bovine serum/phosphate-buffer saline). Finally, we obtained a single final nanoformulation that exhibited a high loading capacity (%EE ≥ 75%) and a sustained drug release profile under physiological conditions (model drug methotrexate), without altering the original physicochemical characteristics of the carrier. With a mean hydrodynamic radius (Rh) of less than 70 nm, a polydispersity index of 0.219, and no protein complexation, the system is a suitable candidate for in vivo, intravenous, and/or intramuscular administration. The cytotoxicity and genotoxicity of both loaded and unloaded carriers were evaluated through the examination of the upregulation or downregulation of apoptosis-related pathways. Multiple conventional 2D and 3D spheroidal conformations were used for these assessments, including HEK293, HCT-116, and MCF-7 cell lines, the results of which stressed the safety and biocompatibility of the empty nanocarrier. Additionally, experiments on Caenorhabditis elegans were conducted to evaluate the system's in vivo toxicity, focusing on developmental stages, egg-laying behavior, and locomotion. Nanosystems studied in terms of chemotherapeutic encapsulation have mostly focused on the physiochemical aspect of the development of such novel delivery platforms, with only few exceptions proceeding step-by-step from cellular 2D to 3D to in vivo experimentation. The present study offers a holistic view of the behavior of such a novel system, advancing our understanding of the capabilities of polymeric/surfactant-based nanodelivery platforms.

Project description:Sentiment quantification is the task of training, by means of supervised learning, estimators of the relative frequency (also called "prevalence") of sentiment-related classes (such as Positive, Neutral, Negative) in a sample of unlabelled texts. This task is especially important when these texts are tweets, since the final goal of most sentiment classification efforts carried out on Twitter data is actually quantification (and not the classification of individual tweets). It is well-known that solving quantification by means of "classify and count" (i.e., by classifying all unlabelled items by means of a standard classifier and counting the items that have been assigned to a given class) is less than optimal in terms of accuracy, and that more accurate quantification methods exist. Gao and Sebastiani 2016 carried out a systematic comparison of quantification methods on the task of tweet sentiment quantification. In hindsight, we observe that the experimentation carried out in that work was weak, and that the reliability of the conclusions that were drawn from the results is thus questionable. We here re-evaluate those quantification methods (plus a few more modern ones) on exactly the same datasets, this time following a now consolidated and robust experimental protocol (which also involves simulating the presence, in the test data, of class prevalence values very different from those of the training set). This experimental protocol (even without counting the newly added methods) involves a number of experiments 5,775 times larger than that of the original study. Due to the above-mentioned presence, in the test data, of samples characterised by class prevalence values very different from those of the training set, the results of our experiments are dramatically different from those obtained by Gao and Sebastiani, and provide a different, much more solid understanding of the relative strengths and weaknesses of different sentiment quantification methods.

Dataset Information

Re-Evaluation of Chemotherapeutic Potential of Pyoktanin Blue.

Publications

Re-Evaluation of Chemotherapeutic Potential of Pyoktanin Blue.

Similar Datasets

OmicsDI is part of the ELIXIR infrastructure

Tweets